The FDA announced that it will not enforce the in-person dispending requirement for mifepristone for the duration of the COVID-19 public health emergency.| www.acog.org
A Q&A with Dr. Nisha Verma, a fellow of ACOG and complex family planning subspecialty trained OB/GYN, and Vanessa Wellbery, ACOG’s Senior State Government Affairs Manager.| www.acog.org